Back to search results
NCT06358261

Study of a Diabetes Prevention Patient Activation Clinical Decision Support Tool

Enrolling by Invitation
NAAges 18+InterventionalPrevention
Johns Hopkins University
~100 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Diabetes Prevention Patient Activation Clinical Decision Support Tool

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
patient activation as assessed by the Patient Activation Measure Survey (PAM)
Measured over baseline, 6 months

Conditions

PreDiabetes
Lifestyle, Healthy
Activation, Patient

Explore related trials

Prediabetes

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Eva Tseng, MD · PRINCIPAL_INVESTIGATOR · Johns Hopkins University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

prediabetes
patient at Johns Hopkins General Internal Medicine clinic at Green Spring Station
MyChart account

Exclusion

history of diabetes
non-English speaker
severe intellectual disability or psychiatric comorbidities

What this trial measures

  • patient activation as assessed by the Patient Activation Measure Survey (PAM)baseline, 6 months

    measured by Patient Activation Measure (PAM) survey, a 13-item scale with 4 Likert response,s and scores ranging from 0 to 100 (higher score means higher activation level)